MetaCap

Kailera Therapeutics Inc. (KLRA)

NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.02-0.56 (-4.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KLRA stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$4.16
52-week range
9.76 – 28.23
Day range
11.00 – 11.87
Volume / Avg
553.23K / 1.08M
Beta
—

52-week range

$9.76$28.23

KLRA stock today

Kailera Therapeutics (KLRA) closed at $11.02 on Nov 20, down 4.84% (-$0.56), versus the S&P 500's 3.70% decline. At this level, KLRA sits near the bottom of its 52-week range of $9.76 to $28.23: 61.0% below the high, set on Apr 20, 2026 and 12.9% above the low. Kailera Therapeutics has posted a net loss over the last twelve months (EPS of -$4.16), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Kailera Therapeutics

Company profile

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Ronald C. Renaud Jr., M.B.A.
Headquarters
Waltham, MA
Employees
145
IPO year
2026

Analyst forecast

Forecast

Consensus (7 analysts)

strong_buy

Avg. price target

$43.00+290.20%

  • Strong buy 1
  • Buy 6
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $30.00High $57.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 11, 2026
EPS actual vs est.
$-0.74 vs $-1.55
Surprise
+52.26%

KLRA news

All KLRA news

Kailera Therapeutics peers

Health Care sector
KLRA peer companies
CompanyPrice% ChgMarket capCompare
SRPTSarepta Therapeutics Inc.13.33-5.93%$1.43Bvs KLRA
DMRADamora Therapeutics Inc.23.22-4.44%$1.44Bvs KLRA
ADRXADARx Pharmaceuticals Inc.12.79-9.68%$1.42Bvs KLRA
NRIXNurix Therapeutics Inc.12.85-5.55%$1.40Bvs KLRA
TYRATyra Biosciences Inc.20.12+1.98%$1.39Bvs KLRA
ANABAnaptysBio Inc.46.63-1.62%$1.39Bvs KLRA
RAPPRapport Therapeutics Inc.23.16-1.82%$1.37Bvs KLRA
QUREuniQure N.V.19.35-4.35%$1.36Bvs KLRA

Indexes, lists and sector

Kailera Therapeutics stock FAQ

What is Kailera Therapeutics's stock price today?

KLRA last traded at $11.02 as of Nov 20, 4:00 PM EST, down 4.84% on the day. Prices are delayed at least 15 minutes.

Who is Kailera Therapeutics's CEO?

Mr. Ronald C. Renaud Jr., M.B.A. is the chief executive officer of Kailera Therapeutics Inc., which has about 145 employees.

What is the KLRA 52-week high?

The 52-week high for KLRA is $28.23 and the 52-week low is $9.76. The stock is currently 61.0% below its high.

Compare KLRA